Jasper Therapeutics
@jaspertx.com
Jasper Therapeutics is a biotechnology company on a mission to make safer and potentially curative therapy possible for more patients in need. We are bringing together a team of biotech veterans, leading academic institutions and a strong syndicate of healthcare-focused investors to achieve our vision of developing new therapies for diseases of mast and stem cells, and safer and more effective conditioning for monogenetic diseases.
Jasper Therapeutics's Company Logos
Jasper Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#F04923
Pomegranate
240, 73, 35
11, 87, 54
0, 70, 85, 6
#F8BB86
Manhattan
248, 187, 134
28, 89, 75
0, 25, 46, 3
#00051E
Blue Charcoal
0, 5, 30
230, 100, 6
100, 83, 0, 88
About Jasper Therapeutics
Jasper Therapeutics is a pioneering biotechnology company dedicated to advancing treatment options for chronic diseases by targeting mast cells and stem cells. With a mission to enhance patient outcomes through safer and potentially curative therapies, Jasper collaborates with industry experts, leading academic institutions, and a network of healthcare investors.
At the forefront of its innovations is Briquilimab (formerly JSP191), a specialized anti-c-Kit monoclonal antibody designed to selectively deplete problematic mast cells and diseased stem cells. This revolutionary treatment is currently being investigated for chronic urticaria, myelodysplastic syndromes, and as a conditioning agent for stem cell transplants in rare genetic disorders like sickle cell disease and Fanconi anemia.
Guided by a seasoned management team with extensive biopharmaceutical experience, Jasper Therapeutics is committed to developing transformative therapies that address significant unmet medical needs in the field of hematology and cell-based treatments. For more information about our vision and ongoing research, please visit our website.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
